Search clinical trials for: Placebo (for suvorexant)

Total 69444 results

The University of Texas Health Science Center,...
Peter F. McManus Charitable Trust

Completed

Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use

Anxiety | Cocaine Use Disorder

United States
Henry Ford Health System

Completed

Study to Compare the Awakening Threshold Effects of Belsomra 10 mg and 20 mg to Placebo in Non-elderly Insomniacs

Insomnia

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Medical Management of Sleep Disturbance During Opioid Tapering

Sleep Disturbance | Opioid Dependence | Opioid Withdrawal

United States
Mclean Hospital

Recruiting

Targeting Orexin to Treat Nicotine Dependence

Nicotine Dependence

United States
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029)

Primary Insomnia
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028)

Primary Insomnia
The University of Texas Health Science Center,...

Recruiting

Suvorexant to Reduce Symptoms of Nicotine Use

Smoking Cessation

United States
Howard University
National Institute of Mental Health (NIMH); Georgetown-Howard Universities...

Completed

Suvorexant and Sleep's Benefits to Therapeutic Exposure for Posttraumatic Stress Disorder

Posttraumatic Stress Disorder

United States
Eisai Inc.
Purdue Pharma LP

Completed

A Study to Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative Users

Insomnia Disorders

Canada
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections

Acute Upper Respiratory Infections

Russian Federation
Henry Ford Health System

Terminated

Suvorexant in Insomnia Co-morbid With Fibromyalgia

Insomnia | Fibromyalgia

United States
Massachusetts General Hospital

Withdrawn

Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia

Insomnia | Bipolar Disorder
Jichi Medical University
Merck Sharp & Dohme LLC; Satt Co.,Ltd

Completed

To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With Insomnia (Super1)

Hypertension | Insomnia

Japan
Beth Israel Deaconess Medical Center
Merck Sharp & Dohme LLC

Recruiting

Suvorexant and Sleep/Delirium in ICU Patients

Insomnia | Sleep Initiation and Maintenance Disorders | Postoperative Delirium | Sleep Fragmentation

United States
University of Maryland, Baltimore
Merck Sharp & Dohme LLC

Recruiting

Insomnia Treatment and EMA (Ecological Momentary Assessment) Outcomes

Insomnia

United States
Institute for Advanced Medical Research, Alpharetta...
Augusta University, Dept. of Psychiatry

Unknown

A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia

Depression | Insomnia | Major Depressive Disorder | MDD

United States
Merck Sharp & Dohme LLC

Completed

Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)

Primary Insomnia
Merck Sharp & Dohme LLC

Completed

A Long Term Safety Study of Suvorexant in Participants With Primary Insomnia (MK-4305-009 AM3)

Insomnia
Howard University
Merck Sharp & Dohme LLC

Completed

Suvorexant and Trauma Related Insomnia

Insomnia | Posttraumatic Stress Disorder

United States
Brigham and Women's Hospital

Completed

Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia

Insomnia

United States
University of California, San Francisco

Completed

The Role of Orexin in Human Panic Disorder

Panic Disorder

United States
Wayne State University
Henry Ford Health System; Ascension Brighton Center for Recovery

Recruiting

Dual-Orexin Antagonism as a Mechanism for Improving Sleep and Drug Abstinence in Opioid Use Disorder

Sleep | Opioid-use Disorder

United States
Medical University of South Carolina
Merck Sharp & Dohme LLC

Not yet recruiting

Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors

Breast Cancer | Insomnia
Duke University
Merck Sharp & Dohme LLC

Recruiting

REPOSE Study: Reducing Delirium by Enhancing Postoperative Sleep With Suvorexant (REPOSE)

Delirium in Old Age

United States
The Florey Institute of Neuroscience and Mental...
Melbourne Health; St Vincent's Hospital Melbourne

Terminated

Suvorexant in the Management Comorbid Sleep Disorder and Alcohol Dependence

Insomnia | Alcohol Use Disorder

Australia
Merck Sharp & Dohme LLC

Completed

Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032)

Insomnia
Washington University School of Medicine
Merck Sharp & Dohme LLC; Good Ventures Foundation

Recruiting

Sleep Trial to Prevent Alzheimer's Disease (SToP-AD)

Sleep | Alzheimer Disease

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate Next Day Effects of MK-4305 on Driving Performance (MK-4305-035 AM1)

Insomnia

Netherlands
EnnovaBio Australia Pharmaceuticals Pty Ltd

Not yet recruiting

A First-in-Human SAD/MAD Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ENC1018 in Healthy Adult Subjects

Healthy
The Scripps Research Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Medication Development in Alcoholism: Suvorexant Versus Placebo

Alcohol Use Disorder (AUD)

United States
ZYUS Life Sciences Inc.
Novotech (Australia) Pty Limited; ZYUS Life Sciences Australia Pty Ltd

Completed

Trichomylin® Safety, Tolerability & Pharmacokinetics in Healthy Adults and First in Human Osteoarthritis Pain Evaluation (HOPE)

Healthy | Osteoarthritis

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of IBI356 in Healthy Participants and in Atopic Dermatitis Patients

Healthy Participants | Atopic Dermatitis Patients

China
Theravance Biopharma

Completed

SAD and MAD Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of TD-1473 in Healthy Subjects

Healthy

United States
Chong Kun Dang Pharmaceutical

Recruiting

A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia

Primary Hypercholesterolemia

Korea, Republic of
Spero Therapeutics
Simbec Research

Completed

A Study of the Safety, Tolerability, and Pharmacokinetics of SPR720 in Healthy Volunteers

Healthy Volunteers

United Kingdom
Walter Reed Army Institute of Research (WRAIR)

Enrolling by invitation

A Comparison of the Physiological and Behavioral Effects of Suvorexant and Zolpidem in Healthy Volunteers: A Randomized, Double-blind, Placebo Controlled Study

Performance Enhancing Product Use

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Recruiting

Measuring Acute Drug Demand in Humans

Opioid Use Disorder | Opioid Dependence

United States
Hanmi Pharmaceutical Company Limited

Completed

Trial to Evaluate the Efficacy and Safety of HCP1302

Hypertension | Erectile Dysfunction
Eli Lilly and Company
OPKO Health, Inc.

Completed

A Study to Test the Combination of Two Different Kinds of Medications for the Treatment of Diabetes

Diabetes Mellitus, Type 2

United States, Puerto Rico
AstraZeneca

Completed

A Study of MEDI7352 in Painful Osteoarthritis of the Knee

Chronic Pain

Germany, Sweden, United Kingdom
Vivozon, Inc.

Completed

Phase I Study to Investigate Safety, Tolerability, and Pharmacokinetics of VVZ-149 Injection (P1_VVZ149IV)

Healthy

Korea, Republic of
Novartis Pharmaceuticals

Completed

A Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH) (ORION-5)

Homozygous Familial Hypercholesterolemia

Hong Kong, Israel, Russian Federation, Serbia, South Africa, Taiwan, Turkey, Ukraine
Vivozon, Inc.

Completed

A Single Ascending Dose Escalation to Investigate Safety and PK of VVZ-149 Injection in Healthy Older Male Volunteers

Healthy
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

Limited-stage Small Cell Lung Cancer (LS-SCLC)

China, France, United States, Spain, Taiwan, Korea, Republic of, Turkey, Italy, Netherlands, Georgia, Germany, Belgium, Poland, Romania
Johns Hopkins University

Recruiting

Suvorexant for Opioid/Stimulant Co-use

Opioid Use Disorder | Stimulant Use Disorder

United States
Hoffmann-La Roche

Completed

A Study With RO4917523 in Patients With Fragile X Syndrome

Fragile X Syndrome

United States
Agios Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Mitapivat (AG-348) in Healthy Adult Participants

Healthy Volunteers

United States
Ahn-Gook Pharmaceuticals Co.,Ltd
Samsung Medical Center; Seoul St. Mary's Hospital; Seoul National University... and other collaborators

Completed

Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean

Allergic Rhinitis | Perennial Allergic Rhinitis | Non-seasonal Allergic Rhinitis

Korea, Republic of
Taipei Veterans General Hospital, Taiwan

Unknown

Far Infrared Therapy on Peripheral Artery Disease in Hemodialysis Patients

Peripheral Artery Disease

Taiwan
Boehringer Ingelheim

Not yet recruiting

A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity

Obesity

Search clinical trials for: Placebo (for suvorexant)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations